GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » Innovid Corp (NYSE:CTV) » Definitions » ROE %

Innovid (Innovid) ROE % : -3.41% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Innovid ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Innovid's annualized net income for the quarter that ended in Dec. 2023 was $-6.6 Mil. Innovid's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $194.5 Mil. Therefore, Innovid's annualized ROE % for the quarter that ended in Dec. 2023 was -3.41%.

The historical rank and industry rank for Innovid's ROE % or its related term are showing as below:

CTV' s ROE % Range Over the Past 10 Years
Min: -20.57   Med: -15.88   Max: -10.03
Current: -16.17

During the past 5 years, Innovid's highest ROE % was -10.03%. The lowest was -20.57%. And the median was -15.88%.

CTV's ROE % is ranked worse than
77.25% of 989 companies
in the Media - Diversified industry
Industry Median: 2.44 vs CTV: -16.17

Innovid ROE % Historical Data

The historical data trend for Innovid's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovid ROE % Chart

Innovid Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
- - -20.57 -10.03 -15.88

Innovid Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.68 -16.77 -38.68 -5.71 -3.41

Competitive Comparison of Innovid's ROE %

For the Advertising Agencies subindustry, Innovid's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovid's ROE % Distribution in the Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Innovid's ROE % distribution charts can be found below:

* The bar in red indicates where Innovid's ROE % falls into.



Innovid ROE % Calculation

Innovid's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-31.911/( (205.928+195.99)/ 2 )
=-31.911/200.959
=-15.88 %

Innovid's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-6.632/( (192.921+195.99)/ 2 )
=-6.632/194.4555
=-3.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Innovid  (NYSE:CTV) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-6.632/194.4555
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-6.632 / 154.468)*(154.468 / 247.592)*(247.592 / 194.4555)
=Net Margin %*Asset Turnover*Equity Multiplier
=-4.29 %*0.6239*1.2733
=ROA %*Equity Multiplier
=-2.68 %*1.2733
=-3.41 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-6.632/194.4555
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-6.632 / -8.568) * (-8.568 / -10.196) * (-10.196 / 154.468) * (154.468 / 247.592) * (247.592 / 194.4555)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.774 * 0.8403 * -6.6 % * 0.6239 * 1.2733
=-3.41 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Innovid ROE % Related Terms

Thank you for viewing the detailed overview of Innovid's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovid (Innovid) Business Description

Traded in Other Exchanges
N/A
Address
30 Irving Place, 12th Floor, New York, NY, USA, 10003
Innovid Corp is a software platform that provides ad serving, measurement and creative services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV and desktop TV environments to advertisers, publishers and media agencies. It is engaged in ad serving, measurement and creative services.
Executives
Anthony Callini officer: Chief Financial Officer C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
David Helmreich officer: Chief Commercial Officer C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Zvika Netter director, officer: Chief Executive Officer C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Gilad Shany director 89 MEDINAT HAYEHUDIM, HERZLIYA L3 4676672
Rachel Lam director C/O TREMOR VIDEO, INC., 53 WEST 23RD STREET, NEW YORK NY 10010
Genevieve Juillard director C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Genesis Partners Iii Lp 10 percent owner POB 12866, HERTZLYIA PITUACH L3 46733
Eddy Shalev 10 percent owner C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Eyal Kishon 10 percent owner C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Kenneth Markus officer: Chief Operating Officer C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Tanya Andreev-kaspin officer: Chief Financial Officer C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Tal Chalozin officer: Chief Technology Officer C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Brian F. Hughes director 124 COLONIAL RIDGE DRIVE, HADDONFIELD NJ 08033
Jonathan Saacks director C/O INNOVID, INC., 30 IRVING PLACE, 12TH FLOOR, NEW YORK NY 10003
Haim Sadger 10 percent owner C/O SEQUOIA CAPITAL, 2800 SAND HILL RD, SUITE 101, MENLO PARK CA 94025